MENU

CADL Candel Therapeutics Forecast, Technical & Fundamental Analysis

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer... Show more

CADL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
CADL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CADL is expected to report earnings to fall 42.31% to -30 cents per share on November 12

Candel Therapeutics CADL Stock Earnings Reports
Q3'26
Est.
$-0.30
Q2'26
Missed
by $0.29
Q1'26
Beat
by $0.20
Q4'25
Missed
by $0.29
Q3'25
Missed
by $0.03
The last earnings report on August 13 showed earnings per share of -51 cents, missing the estimate of -23 cents. With 161.48K shares outstanding, the current market capitalization sits at 640.46M.
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WRAP1.340.01
+0.75%
Wrap Technologies
GRI1.470.01
+0.68%
GRI Bio Inc.
NCDL10.39-0.06
-0.57%
Nuveen Churchill Direct Lending Corp
BKV22.29-0.36
-1.59%
BKV Corp
MKC46.32-1.23
-2.59%
McCormick & Company

CADL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CADL has been loosely correlated with EDIT. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if CADL jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CADL
1D Price
Change %
CADL100%
-3.13%
EDIT - CADL
47%
Loosely correlated
-2.71%
SANA - CADL
46%
Loosely correlated
-0.42%
CRSP - CADL
45%
Loosely correlated
+1.24%
RXRX - CADL
44%
Loosely correlated
-0.55%
BEAM - CADL
43%
Loosely correlated
-0.36%
More
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Industry
N/A
Address
117 Kendrick Street
Phone
+1 617 916-5445
Employees
55
Web
https://www.candeltx.com